Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Veterinary Research

Open Access

Non-cytotoxic Thymus capitata extracts prevent Bovine herpesvirus-1 infection in cell cultures

  • Ramzi Boubaker–Elandalousi1, 2Email author,
  • Marwa Mekni–Toujani1,
  • Belhassen Kaabi1,
  • Imen Larbi1,
  • Mohamed-Fethi Diouani1,
  • Mohamed Gharbi3,
  • Hafidh Akkari3,
  • Fatma B’chir4 and
  • Abdeljelil Ghram1
BMC Veterinary Research201410:231

https://doi.org/10.1186/s12917-014-0231-6

Received: 1 May 2014

Accepted: 22 September 2014

Published: 27 September 2014

Abstract

Background

Bovine herpes virus type 1 (BHV-1) still causes great economic loss to the livestock industry and trade because there aren’t any available drugs that proved to be fully effective against it. In this study, the cytotoxicity and the antiviral activities of the Thymus capitata extracts were evaluated for the development of new, non toxic and specific anti-herpesvirus drug. Aqueous extracts (AE), ethanolic extracts (EE) and essential oil (EO) of the aerial parts of Thymus capitata were analyzed to determine their chemical compositions by gas chromatography, and high performance liquid chromatography combined with mass spectrometry. Their cytotoxicity and antiviral activities against Bovine Herpesvirus type 1 (BHV-1) were evaluated by quantifying the reduction of the viral cytopathic effect using Madin-Darby Bovine Kidney cell line with colorimetric assay. T. capitata extracts were added at different stages of the viral infection to investigate and better quantify their potential inhibitory effects.

Results

Polyphenols and flavonoids were the major compounds found in T. capitata EO, EE and AE. The cytotoxic concentrations at 50% were 48.70, 189 and 289 μg ml−1 for EO, EE and AE, respectively. The inhibitor concentrations at 50% for the EO, EE and AE, were 3.36, 47.80 and 164 μg ml−1, respectively. The selectivity index anti-BHV-1 values were 14.49, 3.95 and 1.81 for EO, EE and AE, respectively. Thus, the EO extracts were the most efficient antiviral compounds. T. capitata extracts affect mainly the adsorption of BHV-1 virus to host cells.

Conclusion

T. capitata extracts inhibit the viral replication by interfering with the early stages of viral adsorption and replication. Thus, T. capitata is a potential candidate for anti-herpesvirus treatment.

Keywords

Thymus capitataCytotoxicityAntiviralMadin-Darby Bovine Kidney cellBovine Herpesvirus type1

Background

Bovine herpesvirus type 1 (BHV-1), a member of the subfamily Alphaherpesvirinae, is a virulent pathogen causing significant economic losses to the livestock industry, worldwide [1]. The virus is associated with a variety of symptoms including rhinotracheitis, vulvovaginitis, balanoposthitis, abortions, conjunctivitis and generalized systemic infections [2]. Infectious bovine rhinotracheitis (IBR), a wide spread enzootic herpetic infection caused by BHV-1, is classified in the list B of diseases by the Office International des Epizooties [2]. BHV-1-induced immunosuppression leads frequently to secondary bacterial infections. Thus, BHV-1 is an important cofactor in the bovine respiratory disease complex which has great financial impacts [1],[2]. Furthermore, BHV-1 has received increasing attention as a surrogate model for anti-herpes virus drug screenings. On the other hand, plant-derived antiviral extracts are of great interest for the development of new, non-toxic, more effective and specific anti-herpesvirus active molecules. Indeed, several trials using plant extracts have shown in vitro anti-BHV-1 activities at early and/or late stages of the viral replication, such as: Phyllanthus orbicularis[3], Erythroxylum deciduum, Lacistema hasslerianum (chodat), Xylopia aromatica[4], Heteropteris aphrodisiaca[5], Acacia nilotica (gum arabic tree) [6], Lippia graveolens (Mexican oregano or redbrush lippia) [7], Guettarda angelica (Velvetseed) [8], Prunus myrtifolia (West Indian cherry), Symphyopappus compressus[9], and Pimpinella anisum (Anise) [10].

A large number of plant extracts from Lamiaceae were also examined for their potential antiviral activity against herpesvirus, such as: Melissa officinalis (lemon balm), Mentha piperita (pepper-mint), Prunella vulgaris (prunella), Rosmarinus officinalis (rosemary), Salvia officinalis (sage) and Thymus vulgaris (thyme) [11]-[14]. Besides, different thyme species have been screened for antibacterial, anthelmintic, antifungal and antioxidant activities, and as immune modulator [15],[16]. However, to the best of our knowledge, cytotoxic and antiviral activities of different T. capitata (Order of Lamiales, Family of Lamiaceae) extracts against BHV-1 have never been tested.

In the present study, we have determined the chemical compositions and the cytotoxicity effects of different extracts of the T. capitata areal parts, collected in Matmata region (Southern Tunisia). The aqueous (AE) and ethanolic extracts (EE) and the essential oil (EO) were tested, since significant differences in antimicrobial activities between these extracts have been previously reported [11],[12].

Methods

Collection and preparation of the plant materials

Fresh T. capitata plants were collected in June 2011 from Matmata locality in the South East of Tunisia (33°32′ North 9°58′ East). Aerial parts of the plants (leaves, stems and flowers) were separated, thoroughly rinsed in running tap water and air dried at room temperature during 14 days, then pulverized, grounded to fine powder and stored at +4°C until use.

Preparation of the extracts

The AE and EE were prepared as previously described by Boubaker Elandalousi et al.[16]. The EO was prepared by dissolving 100 g of dried plant material in 1 liter of distilled water, and then submitted to microwave-assisted hydro-distillation at +40°C during 4 hours, in a Clevenger-type apparatus.

Stock solution (10 mg ml−1) of EO and EE were dissolved in Dulbecco’s modified Eagle’s cell culture medium (DMEM) with 0.5% dimethylsulfoxide (DMSO). All extracts were sterilized by filtration (0.22 mm filter), dried and kept in dark flask at +4°C until tested.

Analyses of T. capitata EO, EE and AE compositions

EO and EE gas chromatography/mass spectrometry (GC/MS) analysis

The GC-MS unit consists on a Perkin-Elmer Autosystem XL gas chromatograph, equipped with HP-5MS fused-5% Phenyl Methyl Siloxane capillary column (Agilent, 30 m×0.25 mm, film thickness 0.25 μm). It is interfaced with Perkin-Elmer Turbo mass spectrometer at specific operating conditions (injector temperature: 250°C; carrier gas: Helium adjusted to a linear velocity of 37 cm s−1; flow rate: 1 ml min−1; volume of injected sample: 1 μl; split ratio: 50:1; ionization energy: 70 Ev; ion source temperature: 200°C; scan mass range m z–1: 50–550 and interface line temperature: 300°C).

AE high performance liquid chromatography/mass spectrometry (HPLC/MS) analysis

HPLC-MS (Agilent, Waldbronn, Germany) separation was performed using an Agilent C18 reverse-phase column (150×4.6 mm) which was maintained at 33°C, with a direct injection of 25 μl of the extract at a 100 bars pressure and a flow rate of 0.25 ml min−1. Elution was performed by gradient mode, using water and acetic acid (999/1 v/v), and acetonitrile in mobile phases. The gradient program was set to 5% for the 5 first minutes, increased linearly to 100% for 65 minutes, remained at 100% for three minutes and decrease to 5% during the last 69 minutes. Chromatographic peaks were investigated with Mass Lynx Software (Waldbronn, Germany).

The Mass spectroscopy (MS) was performed using a Micro mass Quattro Ultima PT MS model (Waldbronn, Germany) at the following operating conditions: capillary voltage (3.20 kV); capillary temperature (300°C); multiplier (550 V) and cone gas flow (60 L Hr−1). The ion trap detector with electro-spray ionization source was used for quantification, and it was set in negative ionization mode.

Extracts constituents were identified by comparing their mass spectra or retention indices as HPLC-MS spectra with those of reference chemical compounds gathered from the Institut National de Recherches et d’Analyses Physico-chimiques, Tunisia - LMS library, and commercially available standards from published libraries.

Cell line

Monolayer cultures of MDBK cell line were grown in DMEM supplemented with 10% fetal calf serum, 100 IU ml−1 penicillin G and 100 mg ml−1 streptomycin. Two hundreds microliters of 1×106 ml−1 cell suspension were put into each well of a 96-well culture plate, for both cytotoxicity and antiviral assays. All plates were maintained in an incubator at 37°C and 5% CO2 atmosphere.

Virus

Stock virus of the Cooper-1 (Colorado-1) strain of BHV-1, obtained from the American Type Culture Collection (Rockville, MD, USA), was propagated in MDBK cell cultures. The infected cell supernatant fluids were harvested, titrated and stored at −80°C until use.

For the virus titration, MDBK cells were seeded in 24-well culture plate and incubated at 37°C. After 24 hours, serial dilutions of the virus stock were prepared in culture medium, and each dilution was added to 4 wells. After an additional 72 hours of incubation, the cytopathic effect (CPE) in each well was recorded. The viral Titer of BHV-1 was calculated by Reed and Muench method, as described previously [17].

Cytotoxicity assays

To examine the effect of T. capitata extracts on the growth and the viability of the cultured cells, serial dilutions of extracts (from 5 to 500 μg ml−1) were prepared in DMEM, in triplicate, and 200 μl of each dilution was added to the 96-well culture plates. The maximum non-toxic concentration (MNTC) was determined by cell morphology alterations, estimated under a light microscope at ×100 magnifications during the 3 days incubation at 37°C. Monolayer cells incubated with only DMEM were used as cell controls. The cells were fixed with 1% glutaraldehyde for 10 min, stained with 0.1% crystal violet during 30 min, and the optical density was determined by a spectrophotometer at 620 nm wavelength. The cell viability was calculated using the following formula:
Cell viability % = 100 × Ab s sample Ab s cell free blank / Ab s mean media control

Abs: the absorbance

The 50% cytotoxic concentration (CC50) was calculated as the concentration causing 50% cell death.

Antiviral assays

Only non cytotoxic and antiviral concentrations of each plant extract below the MNTC (EO: 2, 3, 4 and 5 μg ml−1; EE: 50, 55 and 60 μg ml−1 and AE: 160, 170 and 180 μg ml−1) were tested to assess anti-BHV-1 activity.

To elucidate the mode of antiviral action, the MDBK cells were incubated with various plant extracts for 3 days, following 3 scenari: before and after viral infection, simultaneous infection.

Cell culture pretreatment (before infection)

Pre-treatment of cell cultures was performed by exposing the cell monolayers to different concentrations of the test compounds in maintenance medium (200 μl) for 2 hours at 37°C. After treatment, the cell monolayers were washed thoroughly with phosphate buffered saline (PBS), infected with 200 μl BHV-1 suspension at 103 Tissue Culture Infective Dose 50% (TCID50) ml−1 of virus and observed for viral cytopathic activity during 72 hours incubation.

Inhibition of virus attachment (simultaneous infection) assay

BHV-1 suspension at a viral concentration of 103TCID50 ml−1 of virus was mixed (v/v: 100 μl) with different concentrations of the test extracts at room temperature. Then, cells were incubated immediately with 200 μl of the mixtures for 72 hours at 37°C and 5% CO2 atmosphere.

Post-infection assay

Two hundred microliters of viral suspension at 103 TCID50 ml−1 in culture medium were adsorbed to MDBK cells for 2 hours at 37°C. Cells were then washed with PBS, and the medium was replaced with 200 μl DMEM containing the EO, EE and AE of T. capitata at serial dilutions, which were then incubated for 72 hours at 37°C and 5% CO2 atmosphere.

The controls consisted of untreated infected cells for virus control, confluent monolayer cells were infected with the virus at 103 TCID50 ml−1 of virus; treated uninfected cells for plant extract controls; and untreated uninfected cells for cell control. After 3 days of incubation, the optical density (OD) was determined as previously described. The level of antiviral activity of the plant extracts was calculated using the following formula:
Antiviral activity % = 100 × Ab s sample - Ab s virus control / Ab s cell control - Ab s virus control

The absorbance (Abs) of the virus control was calculated by mixing 100 μl ×103 TCID50 of virus suspension with 100 μl of culture medium without plant extracts. The absorbance of cell controls was estimated by mixing 100 μl of MNTC of each extracts with 100 μl of culture medium [18]. The 50% effective antiviral concentration (IC50) was calculated as the antiviral concentration causing 50% inhibition of virus-induced CPE. The selectivity index (SI) was calculated as the ratio of CC50 and IC50.

Statistical analysis

The data are presented as means ± standard deviation (S.D). The T-test was used to compare differences between mean groups. A correlation test between concentration extracts and viral inhibition was also performed. A p-value < 0.05 was considered to imply statistical significance. The statistical analysis were performed using the R software for statistical computing (v3.01, available from: www.r-project.org), and GraphPad Prism software®, release 3.0.

Results

The results of the chemical composition and the cytotoxic and antiviral activities of each plant extract are presented in Tables 1, 2, and 3, respectively.
Table 1

List of chemical compounds (descending order) in essential oil and ethanolic extract identified by GC–MS and in aqueous extract identified by HPLC-MS of Thymus capitata

Molecule

Essential oil (%)

Ethanolic extract (%)

Aqueous extract

3-Methyl-4-isopropylphenol: thymol

73.38

71.22

Apigenin-6,8- di C-glucoside

Camphor

ND

17.18

Luteolin-7- rutinoside

Benzene

10.86

6.32

Hesperidin

Caryophyllene

2.55

1.11

Apigenin-7- glucoronide

Linalool

1.97

ND

Eupafolin- glucoside

Caryophyllene oxide

1.87

0.98

Acethyl- luteolin- glucuronide

3-Cyclohexen-1-ol

0.92

0.61

Rosmarinic Acid

3-Cyclohexen-1-ol

0.92

ND

 

1,6-Octadien-3-ol

ND

0.83

 

Eugenol

0.81

ND

 

Borneol

0.78

0.64

 

Beta.-Myrcene

0.72

0.15

 

Dimethyl Sulfoxide

0.56

ND

 

(+)-4-Carene

0.50

ND

 

3 Hydroxy-1-octene

0.41

ND

 

4,5-epoxy-1-isopropyl-4-methylcyclohexane

ND

0.29

 

Phenol

0.28

0.26

 

Phenol, 2,3,4,6-tetramethyl

0.22

ND

 

3-Octanol

0.20

ND

 

1,4-Cyclohexadiene

0.18

ND

 

Octahydrophenanthrene

0.14

ND

 

2,6,11,15-Tetramethyl-hexadeca-2, 6,8,10,14-pentaene

0.14

ND

 

Naphthalene

0.12

ND

 

Alpha.-Caryophyllene

0.12

ND

 

Endo-Borneol

0.11

ND

 

Lopentadiene

0.09

ND

 

Trans-Linalool oxide

0.05

ND

 

Phenol Carvacrol

0.04

ND

 

Acetaminophenol

0.04

ND

 

Phenanthrene

0.03

ND

 

Total

98.01

99.59

 

ND: Not detected.

Table 2

Cytotoxic activities of essential oil, ethanolic and aqueous extracts of Thymus capitata

Concentration (μg ml−1)

Mean cell survival percentage ± standard deviation

Essential oil (n = 3)

Ethanolic extract (n = 3)

Aqueous extract (n = 3)

5

100 ± 1.03

95.63 ± 3.31

NA

10

93.50 ± 1.13

93.18 ± 3.87

NA

20

84.51 ± 1.59

96.05 ± 2.87

NA

50

47.42 ± 0.64

92.83 ± 3.27

100 ± 0.74

100

14.77 ± 0.07

79.61 ± 3.64

92.21 ± 2.41

200

2.91 ± 0.03

45.83 ± 1.90

74.20 ± 1.71

300

1.63 ± 0.05

28.97 ± 1.90

48.35 ± 1.21

500

1.21 ± 0.04

26.80 ± 1.47

28.68 ± 0.38

NA: Not applicable.

Table 3

Antiviral activities of selected Thymus capitata extracts against bovine herpesvirus type1

Extract

Yielda(%)

CC50b(μg ml−1)

IC50c(μg ml−1)

SId

Essential oil

1

48.70

3.36

14.49

Ethanolic extract

10.05

189

47.80

3.95

Aqueous extract

3.25

298

164

1.81

a% w/w = g of extracts 100 g−1 of dried and ground plant material.

bCytotoxic concentration 50%; c: inhibitor concentration 50%;

dSelectivity index = CC50/IC50.

Chemical analysis of Thymus capitata EO, EE and AE

A total number of 28 components were identified in T. capitata EO; phenols were the major constituents, mainly the 3-Methyl-4-isopropylphenol: thymol (73.38%). Other compounds were also present but with lower concentrations such as caryophyllene (sesquiterpene, 2.55%), linalool (monoterpene, 1.97%), eugenol (phenol, 0.81%) and borneol (monoterpene, 0.78%). Aromatic hydrocarbons (benzene, naphthalene, anthracen) and terpens (myrecen, caren) were also present in T. capitata EO with lower concentrations (Table 1).

Twelve compounds were identified in EE; most of them were phenols such as 3-Methyl-4-isopropylphenol or thymol (71.22%), camphor (17.18%), benzene (6.32%) and caryophyllene (1.11%) (Table 1).

Apigenin and luteolin derivatives were the most abundant phenolic compounds (flavonoid) found in AE, whilst rosmarinic acid was a minor one (Table 1).

Several phenolic components were present with roughly the same concentrations in both EO and EE, mainly 3-Methyl-4-isopropylphenol: thymol (73.38% and 71.22%, respectively) followed by benzene (10.86% and 6.32%, respectively).

Cytotoxicity

To examine the effect T. capitata extracts on the growth and the viability of cultured cells, EO, EE and AE were serially diluted and added to cell culture medium (Figure 1A).
Figure 1

Cytotoxicity and cytopathic effects on Madin-Darby Bovine Kidney cells (×100) after addition of EO, EE and EA of Thymus capitata before infection with 10 3 TCID 50 ml −1 of Bovine herpesvirus type 1 (BHV-1). A: Cell control, not infected with BHV-1, after 72 hours of incubation. B: Virus control (cytopathic effect), untreated MDBK cell culture, 72 hours after BHV-1 infection with 103 TCID50 ml−1. C: Cytotoxic effect, MDBK treated with extracts of EO (50 μg ml−1), 72 hours of incubation. D: Viral inhibition, MDBK cells were pre-treated with EO (5 μg ml−1) for 2 h, then infected with BHV-1 at 103 TCID50 ml−1.

The cytotoxicity effect was characterized by aggregation of degenerated cell clusters detaching from the bottom of the wells forming holes (gap formation) within the cell monolayer (Figure 1C). The results of cytotoxic effects of each plant extract are represented in Table 2. No effect was observed at the concentrations varying from 5 to 10 μg ml−1 for EO, 10 to 100 μg ml−1 for EE and 5 to 200 μg ml−1 for AE. The CC50 values determined by the colorimetric assay were 48.70 μg ml−1, 189 μg ml−1 and 298 μg ml−1 for EO, EE and AE, for concentrations up to 10, 100 and 200 μg ml−1 of EO, EE and AE, respectively. Cytotoxicity was detected when degenerated cells become round and float in the medium with more prominent nuclei. The EO induced the highest cytotoxic effect, while EE and AE induced moderate and low cytotoxicity effect, respectively.

Virus inhibition

The viral CPE usually appeared within 3 days after inoculation. The CPE of BHV-1 is characterized by cell rounding and ballooning, forming grape-like clusters of spherical cells gathered around a gap in the monolayer. Sometimes, giant cells with several nuclei may be observed (Figure 1B).

At MNTC of plant extracts, viral CPE was significantly reduced (p-values < 0.05) and the anti-BHV-1 activity showed a dose dependant response (Figure 2A and B). The IC50 were 3.36, 47.8 and 164 μg ml−1 for EO, EE and AE, respectively. According to the SI values, the highest antiviral activity was seen with EO followed by that of EE and AE (Table 3). Indeed, a high cytotoxic value and a low inhibitory concentration gave the highest selectivity index for EO, indicating that it is the most effective antiviral extract (Table 3).
Figure 2

Percentage of viral inhibition by different Thymus capitata extracts: Essential oil (2, 3, 4 and 5 μg ml −1 ), Ethanolic extract (50, 55 and 60 μg ml −1 ) and Aqueous extract (160, 170 and 180 μg ml −1 ) were tested during (A) and after (B) infection of MDBK cells with 10 3 TCID 50 ml −1 of Bovine herpesvirus type 1.

When host cells were treated with extracts prior to infection, no CPE of t BHV-1 infection was observed (Figure 1D). Thus, pre-treatment of MDBK cells with T. capitata EO, EE and AE completely inhibited BHV-1 infectivity (p-value < 0.05). However, when T. capitata EO, EE or AE were added during or after virus penetration, the viral CPE of the BHV-1 was significantly reduced in a dose dependant manner (p-value < 0.05) (Figure 2A; B).

A very significant correlation was found between AE concentration and viral inhibition in the interval [160, 180 μg ml−1] of AE concentration.

Discussion

The analyses of the composition of EO, EE and AE of Tunisian T. capitata revealed the predominance of phenolic compounds (Table 1). Thymol: 3-Methyl-4-isopropylphenol was the major component found in both EO and EE. Caryophyllene was present in low concentrations in EO and EE. However, camphor, linalool, eugenol and borneol were only identified in EE and EO, respectively. Interestingly, AE exhibited the largest amount of apigenin- and luteolin as phenolic (flavones) compounds. In contrast, rosmarinic acid was found to be a minor compound in AE (Table 1). These findings are in accordance with those reported in previous studies on T. capitata from South Tunisia and other countries [14],[19]. Mkaddem et al.[19] showed that the major EO compound in T. capitata was thymol, using plants from the same region. Also, Behravan et al.[14] showed that thymol and carvacrol were the major compounds in T. capitata EO from Iran. However, other studies showed geographic variations of chemical compositions of T. capitata extracts [15],[20]. Nolkemper et al.[11] found that rosmarinic acid was the most abundant compound of the same genus T. vulgaris AE. In fact, bioactive molecule types and amount variations from T. capitata depend on the geographic distribution (climate, soil type), the collecting season, as well as, the plant part [20],[21].

In the present study, T. capitata extracts exhibited an in vitro cytotoxic activity with CC50 values varying from 48.70 to 298 μg ml−1, depending on the type used in the same biological conditions (Table 2). When referring to the in vitro and the predicted in vivo substance toxicity classification of Halle and Göres [22], T. capitata EO, EE and AE are considered to exhibit a relatively low toxicity; the most toxic extract being EO.

Cytotoxic activities of EO or its major components were demonstrated, in vitro, in mammalian cells to be moderate to high [22]. Indeed, EO induced some defects in the cell respiratory system (permeabilization of outer and inner mitochondrial membranes), usually directly associated with cell death by apoptosis and necrosis [23]. In general, the cytotoxic activity of EO is mostly due to the presence of phenols. However, flavones are the cytotoxic components present in AE and have been reported to exhibit cytotoxic activity at high concentrations towards normal non infected human cells [24]. Furthermore, it has been suggested that when flavonoids are introduced into cells, they increase the intracellular reactive oxygen species levels, and exert their cytotoxicity effect [24]. According to previous studies, CC50 values of T. vulgaris were 70, 62.3 [12] and 62 μg ml−1[11] for EO, EE and AE, respectively. The difference in AE chemical compositions between T. capitata and T. vulgaris may explain the observed CC50 values. The rosmarinic acid was the most abundant compound in T. vulgaris. However, for South Tunisia, T. capitata AE, apigenin and luteolin were the major compounds and rosmarinic acid was the minor extracted compound. Nolkemper et al.[11] showed that for aqueous Lamiaceae plant extracts, the CC50 varied between 55 and 125 μg ml−1 due to differences in their phenolic compounds’ concentrations.

In the present study, the inhibitory effect of thyme EO against BHV-1 infection was compared to the antiviral activity of EE and AE (Table 3). Both T. capitata extracts were shown to affect significantly BHV-1 replication (p value < 0.05). Previous in vitro experiments showed similar results for EO, EE and AE from Lamiaceae plant including Thymus spp.[11],[12].

The thyme EO revealed a higher antiviral activity and a SI of 14.49, whereas EE and AE showed lower SIs (Table 3). The anti-herpes virus activities of several EOs of different plant sources as well as of some constituents of EOs were reported previously, e.g. peppermint oil, thyme oil and anise oil [10],[25],[26]. The presence of thymol and β-caryophyllene in EO may strongly contribute to their antiviral effect which is in agreement with our results and as described by others [14],[27].

Pre-treatment of cells with different T. capitata extracts, at the tested concentrations, completely inhibited viral CPE (Figure 1D). In addition, an antiviral activity dose dependent effect was significantly observed (p-value < 0.05) for EO, EE and AE when added during or after cell infection (Figure 2A; B). A very significant correlation was found between AE concentration and viral inhibition in the interval [160, 180 μg ml−1]. These results suggested that these biomolecules may interfere with either viral particles and/or virus envelope, and may mask viral structures or cell receptors necessary for the virus adsorption and entry into the host cells. In fact, Schnitzler et al.[13] reported that balm oil, abundant in phenolic compounds, affected the viruses in vitro when added before viral adsorption, although the mechanism of action is still unknown. It is suggested that the balm oil could bind to the viral proteins involved in the host adsorption and penetration, or damage the virus envelope. In several cases, plant-derived polyphenols exhibit anti-herpesvirus activity mostly by influencing the early phases of infection [18]. Furthermore, Reichling et al.[12] concluded that ethanolic plant extracts affect herpesvirus prior to and during adsorption. They suggested that the antiviral activity is due to the association of the extracts with proteins of the host cell surface molecules, resulting in reduction or prevention of viral adsorption.

Flavonoid derivatives have also been reported to possess antiviral activity against a wide range of viruses [28]-[30]. Apigenin 7-O-glucoside and luteolin are flavonoid compounds that are found in lemon balm (Melissa officinalis), chamomile (Chamomilla recutita), and celery (Apium graveolens) and have shown antiviral activity in vitro[28],[31]. The extracts of basil (Ocimum basilicum) and their purified compounds, including apigenin, were tested against a number of viruses (herpesvirus, adenovirus, and hepatitis B virus), and have displayed a broad range of antiviral action, which is in accordance with our data [32].

The mechanism of antiviral action of polyphenolic compounds is mainly due to inhibition of viral enzymes, disruption of cell receptors, prevention of viral binding and penetration into cells. Finally, some natural compounds are reported to have the capacity to interfere with herpesvirus enzymes (DNA polymerase inhibition by eugenol), and thus viral replication [33].

Conclusion

Thymus capitata EO, EE and AE affect (below cytotoxic concentration) mainly the adsorption of BHV-1 virus to Madin-Darby Bovine Kidney host cells. This activity can be explained by the presence of some flavonoids such as apigenin, luteolin or rosmarinic acid in the AE and the presence of polyphenols as thymol in EE and EO. During pre-treatment of MDBK cells, all tested extracts of T. capitata inhibit viral attachment to cell receptors making them good candidates against viral infection. Moreover, a dose-dependent effect was recorded during and after viral infections for the three T. capitata extracts tested.

Authors’ contributions

RB-E, MM-T, BK, IL, M-FD, MG, HA, FB, and A-JG designed the study and participated in plant selection and collection, spectral analyses and in the drafting and correction of the manuscript., RB-E, MM-T, BK, IL, M-FD, FB and A-JG performed GC/SM, HPLC/SM analyses of the plant extracts and carried out the cytotoxicity and antiviral assay. They also contributed to data analysis and critically revised the manuscript. All the authors read and approved the final manuscript version.

Abbreviations

GC/MS: 

Gas chromatography–mass spectrometry

HPLC/MS: 

Performance liquid chromatography/mass spectrometry

EO: 

Essential oil

EE: 

Ethanolic extract

AE: 

Aqueous extract

BHV-1: 

Bovine herpesvirus type 1

DMEM: 

Dulbecco’s modified Eagle’s medium

DMSO: 

Dimethylsulfoxide

MNTC: 

Maximum non-toxic concentration

MDBK: 

Madin-Darby Bovine Kidney

CPE: 

Cytopathic effect

TCID50

The 50% Tissue Culture Infective Dose

IC50

The 50% effective antiviral concentration

CC50

The 50% cytotoxic concentration

SI: 

The selectivity index

Declarations

Acknowledgements

This work received financial support from the «Laboratoire d’épidémiologie et microbiologie vétérinaire », Institut Pasteur of Tunis (Ministère de l’enseignement supérieur et de la recherche, Tunisia)

Authors’ Affiliations

(1)
Laboratoire d’Epidémiologie et Microbiologie Vétérinaire, Institut Pasteur de Tunis, Université Tunis El Manar
(2)
Institut Supérieur de Biotechnologie, BiotechPôle, Université de la Manouba
(3)
Laboratoire de Parasitologie, École Nationale de Médecine Vétérinaire de Sidi Thabet, Université de la Manouba
(4)
Laboratoire des Substances Naturelles, Institut National de Recherche et d’AnalysePhysico-chimique - Pôle Technologique Sidi Thabet, Université de la Manouba

References

  1. Biswas S, Bandyopadhyay S, Dimri U, Patra PH: Bovine herpesvirus-1 (BHV-1) – a re-emerging concern in livestock: a revisit to its biology, epidemiology, diagnosis, and prophylaxis. Vet Quarterly. 2013, 33: 68-81. 10.1080/01652176.2013.799301.View ArticleGoogle Scholar
  2. Jones C, Chowdhury S: Bovine herpesvirus type 1 (BHV-1) is an important cofactor in the bovine respiratory disease complex. Vet Clin North Am Food Anim Pract. 2010, 26: 303-321. 10.1016/j.cvfa.2010.04.007.View ArticlePubMedGoogle Scholar
  3. del Barrio G, Parra F: Evaluation of the antiviral activity of an aqueous extract from Phyllanthus orbicularis. J Ethnopharmacol. 2000, 72: 317-322. 10.1016/S0378-8741(00)00228-2.View ArticlePubMedGoogle Scholar
  4. Simoni IC, Manha APS, Sciessere L, Hoe VMH, Takinami VH, Fernandes MJB: Evaluation of the antiviral activity of Brazilian cerrado plants against animal viruses. Virus Rev Res. 2007, 12: 25-31.View ArticleGoogle Scholar
  5. Melo FL, Benati FJ, Junior WAR, Mello JCP, Nozaw C, Carvalho Linhares RE: The in vitro antiviral activity of an aliphatic nitro compound from Heteropteris aphrodisiaca. Microbiol Res. 2008, 163: 136-139. 10.1016/j.micres.2006.03.011.View ArticlePubMedGoogle Scholar
  6. Gupta D, Goel A, Bhatia AK: Studies on antiviral property of Acacia nilotica. J Env Res Dev. 2010, 5: 141-152.Google Scholar
  7. Pilau MR, Alves SH, Weiblen R, Arenhart S, Cueto AP, Lovato LT: Antiviral activity of the Lippia graveolens (mexican oregano) essential oil and its main compound carvacrol against human and animal viruses. Braz J Microbiol. 2011, 42: 1616-1624. 10.1590/S1517-83822011000400049.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Barros AV, Araújo LM, Oliveira FF, Conceição AO, Simoni IC, Fernandes MJB, Arns CW: In vitro evaluation of the antiviral potential of Guettarda angelica against animal herpesviruses. Acta Scientiae Veterinariae. 2012, 40: 1068-1075.Google Scholar
  9. Fernandes MJB, Barros AV, Melo MS, Simoni IC: Screening of Brazilian plants for antiviral activity against animal herpesviruses. J Med Plants Res. 2012, 6: 2261-2265.Google Scholar
  10. Abdallah FM, Sobhy H, Enan G: Evaluation of antiviral activity of selected anise oil as an essential oil against Bovine herpesvirus type -1 in vitro. Glob Veterinaria. 2013, 10: 496-499.Google Scholar
  11. Nolkemper S, Reichling J, Stintzing FC, Carle R, Schnitzler P: Antiviral effect of aqueous extracts from species of the Lamiaceae family against herpes simplex virus type 1 and type 2 in vitro. Planta Med. 2006, 72: 1378-1382. 10.1055/s-2006-951719.View ArticlePubMedGoogle Scholar
  12. Reichling J, Nolkemper S, Stintzing FC, Schnitzler P: Impact of ethanolic lamiaceae extracts on herpes virus infectivity in cell culture. Forsch Komplementmed. 2008, 15: 313-320. 10.1159/000164690.View ArticlePubMedGoogle Scholar
  13. Schnitzler P, Schuhmacher A, Astani A, Reichling J: Melissa officinalis oil affects infectivity of enveloped herpesviruses. Phytomed. 2008, 15: 734-740. 10.1016/j.phymed.2008.04.018.View ArticleGoogle Scholar
  14. Behravan J, Ramezani M, Nobandegani FE, Gharaee ME: Antiviral and antimicrobial activity of Thymus transcaspicus essential oil. Pharmacol Online. 2011, 1: 1190-1199.Google Scholar
  15. Jabri–Karoui I, Bettaieb I, Msaada K, Hammami M, Marzouk B: Research on the phenolic compounds and antioxidant activities of Tunisian Thymus capitata. J Funct Foods. 2012, 4: 66-69. 10.1016/j.jff.2011.08.001.View ArticleGoogle Scholar
  16. Boubaker Elandalousi R, Akkari H, B’chir F, Gharbi M, Mhadhbi M, Awadi S, Darghouth MA: Thymus capitata from Tunisian arid zone: chemical composition and in vitro anthelmintic effects on Haemonchus contortus. Vet Parasitol. 2013, 197: 374-378. 10.1016/j.vetpar.2013.05.016.View ArticlePubMedGoogle Scholar
  17. Reed IJ, Muench H: A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938, 27: 493-497.Google Scholar
  18. Chattopadhyay D, Chawla Sarkar M, Chatterjee T, Dey R, Bag P, Chakrabarty S, Khan MTH: Recent advancements for the evaluation of antiviral activities of natural products. New Biotechnol. 2009, 25: 347-368. 10.1016/j.nbt.2009.03.007.View ArticleGoogle Scholar
  19. Mkaddem MG, Romdhane M, Ibrahim H, Ennajar M, Lebrihi A, Mathieu F, Bouajila J: Essential oil of Thymus capitata Hoff. et Link. from Matmata, Tunisia: gas chromatography-mass spectrometry analysis and antimicrobial and antioxidant activities. J Med Food. 2009, 13: 1500-1504. 10.1089/jmf.2009.0117.View ArticleGoogle Scholar
  20. Saei–Dehkordi SS, Tajik H, Moradi M, Khalighi–Sigaroodi F: Chemical composition of essential oils in Zataria multiflora Boiss. from different parts of Iran and their radical scavenging and antimicrobial activity. Food Chem Toxicol. 2010, 48: 1562-1567. 10.1016/j.fct.2010.03.025.View ArticlePubMedGoogle Scholar
  21. Loziene K, Venskutonis PR: Influence of environmental and genetic factors on the stability of essential oil composition of Thymus pulegioides. Biochem Syst Ecol. 2005, 33: 517-525. 10.1016/j.bse.2004.10.004.View ArticleGoogle Scholar
  22. Halle W, Göres E: Prediction of LD50values by cell culture.Pharmazie 1987, 42:245-248.PubMedGoogle Scholar
  23. Bakkali F, Averbeck S, Averbeck D, Idaomar M: Biological effects of essential oils - a review. Food Chem Toxicol. 2008, 46: 446-475. 10.1016/j.fct.2007.09.106.View ArticlePubMedGoogle Scholar
  24. Matsuo M, Sasaki N, Saga K, Kaneko T: Cytotoxicity of flavonoids toward cultured normal human cells. Biol Pharm Bull. 2005, 28: 253-259. 10.1248/bpb.28.253.View ArticlePubMedGoogle Scholar
  25. Schuhmacher A, Reichling J, Schnitzler P: Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and 2 in vitro. Phytomed. 2003, 10: 504-510. 10.1078/094471103322331467.View ArticleGoogle Scholar
  26. Koch C, Reichling J, Schneele J, Schnitzler P: Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomed. 2008, 15: 71-78. 10.1016/j.phymed.2007.09.003.View ArticleGoogle Scholar
  27. Astani A, Reichling J, Schnitzler P: Screening for antiviral activities of isolated compounds from essential oils. Evid Base Complement Altern Med. 2011, 44: 8-15.Google Scholar
  28. Akula SM, Hurley DJ, Wixon RL, Wang C, Chase CC: Effect of genistein on replication of bovine herpesvirus type 1. Am J Vet Res. 2002, 63: 1124-1128. 10.2460/ajvr.2002.63.1124.View ArticlePubMedGoogle Scholar
  29. Nowakowska Z: A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem. 2007, 42: 125-137. 10.1016/j.ejmech.2006.09.019.View ArticlePubMedGoogle Scholar
  30. Özçelik B, Kartal M, Orhan I: Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids. Pharm Biol. 2011, 49: 396-402. 10.3109/13880209.2010.519390.View ArticlePubMedGoogle Scholar
  31. Andres A, Donovan SM, Kuhlenschmidt MS: Current Topics Soy isoflavones and virus infections. J Nutr Biochem. 2009, 20: 563-569. 10.1016/j.jnutbio.2009.04.004.View ArticlePubMedGoogle Scholar
  32. Chiang LC, Ng LT, Cheng PW, Chiang W, Lin CC: Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol. 2005, 32: 811-816. 10.1111/j.1440-1681.2005.04270.x.View ArticlePubMedGoogle Scholar
  33. Felipe AMM, Rincão VP, Benati FJ, Linhares REC, Galina KJ, de Toledo CEM, Lopes GC, de Mello JCP, Nozawa C: Antiviral effect of Guazuma ulmifolia and Stryphnodendron adstringens on poliovirus and bovine herpesvirus. Biol Pharm Bull. 2006, 29: 1092-1095. 10.1248/bpb.29.1092.View ArticlePubMedGoogle Scholar

Copyright

© Boubaker–Elandalousi et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement